The rabies immune globulin (RIG) market is anticipated to grow at a significant CAGR of 3.8% during the forecast period (2022-2028). RIG is a hyperimmune globulin made from persons who have been inoculated against rabies and have extremely high antibody titers. The RIG is used to treat people who have been exposed to rabid animals. The major factor […]
